This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignee: Genfit. Active years: 2018-2026.
Company Filing History:
Years Active: 2018-2026
Title: Zouher Majd: Innovator in RORgamma Modulation
Introduction
Zouher Majd, based in Ennetières-en-Weppes, France, is a prominent inventor with a notable portfolio of six patents. His innovative work primarily focuses on RORgamma modulators, contributing significantly to the field of therapeutic treatments for various diseases.
Latest Patents
Zouher's latest patents revolve around the development of novel compounds that act as modulators of RORgamma. These compounds have been detailed in his patent applications, providing pharmaceutical compositions intended for treating diseases where RORgamma modulation could be beneficial. This includes conditions such as autoimmune diseases, inflammatory diseases, metabolic disorders, and fibrotic diseases, showcasing a strong potential for impactful medical applications.
Career Highlights
Zouher Majd works at Genfit, a company recognized for its focus on innovative medical solutions. His dedication to research and development in the field of pharmaceutical sciences positions him as a key figure in the advancement of treatments targeting critical health issues.
Collaborations
Throughout his career, Zouher has collaborated with distinguished colleagues, including Jean-Francois Delhomel and Robert Walczak. These partnerships highlight the collaborative spirit within the research community, fostering the development of cutting-edge medical innovations.
Conclusion
Zouher Majd's contributions to the field of patentable inventions, particularly in RORgamma modulation, demonstrate his commitment to advancing healthcare solutions. His innovative compounds hold promise for transforming treatment approaches for a variety of diseases, underscoring the importance of continued research and development in this vital area.